INTINI, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.985
AS - Asia 1.752
EU - Europa 1.146
SA - Sud America 423
AF - Africa 56
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.365
Nazione #
US - Stati Uniti d'America 4.944
SG - Singapore 740
CN - Cina 569
BR - Brasile 369
SE - Svezia 334
HK - Hong Kong 245
RU - Federazione Russa 151
UA - Ucraina 149
IT - Italia 134
DE - Germania 117
FI - Finlandia 107
GB - Regno Unito 60
VN - Vietnam 60
IN - India 44
CA - Canada 22
CI - Costa d'Avorio 18
FR - Francia 18
BE - Belgio 16
ZA - Sudafrica 16
AR - Argentina 14
BD - Bangladesh 14
IE - Irlanda 14
MX - Messico 13
IQ - Iraq 12
TR - Turchia 11
IR - Iran 10
PL - Polonia 10
EC - Ecuador 9
MA - Marocco 9
ID - Indonesia 8
CZ - Repubblica Ceca 7
PY - Paraguay 7
SA - Arabia Saudita 7
AT - Austria 6
CO - Colombia 6
ES - Italia 6
JP - Giappone 6
VE - Venezuela 6
CL - Cile 5
JO - Giordania 5
KE - Kenya 5
PK - Pakistan 5
NL - Olanda 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
PE - Perù 2
PT - Portogallo 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
Totale 8.365
Città #
Fairfield 696
Woodbridge 460
Chandler 440
Ashburn 394
Singapore 349
Jacksonville 314
Houston 289
Seattle 282
Nyköping 276
Hong Kong 243
Cambridge 236
Wilmington 210
Ann Arbor 156
Beijing 130
Nanjing 128
New York 101
Lawrence 92
Roxbury 92
Boardman 87
Princeton 70
Des Moines 62
Bari 59
Nanchang 51
Los Angeles 49
Brooklyn 39
Inglewood 39
São Paulo 32
Dallas 30
Ho Chi Minh City 28
San Diego 28
Helsinki 27
Jiaxing 26
Dearborn 25
Santa Clara 25
Buffalo 24
Shenyang 24
Pune 20
Abidjan 18
Hebei 18
Rio de Janeiro 18
Munich 17
San Mateo 17
Brussels 16
Tianjin 16
Changsha 15
Kunming 14
Hanoi 13
Jinan 12
Johannesburg 12
Leawood 12
Dublin 11
Molfetta 11
Chicago 10
Guangzhou 10
San Francisco 10
Ardabil 9
Curitiba 9
Noicattaro 9
Belo Horizonte 8
Corridonia 8
Monmouth Junction 8
Warsaw 8
Denver 7
Mumbai 7
Shanghai 7
Stockholm 7
Washington 7
Birmingham 6
Brno 6
Jakarta 6
Lanzhou 6
Lauterbourg 6
London 6
Toronto 6
Amman 5
Augusta 5
Baghdad 5
Brasília 5
Fortaleza 5
Montreal 5
Moscow 5
Nairobi 5
Paris 5
Taizhou 5
Tokyo 5
Atlanta 4
Boston 4
Campo Grande 4
Cuiabá 4
Marseille 4
Montevideo 4
Norwalk 4
Nuremberg 4
Phoenix 4
Quito 4
Riyadh 4
Wuhan 4
Zhengzhou 4
Adelfia 3
Ankara 3
Totale 6.132
Nome #
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 196
Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects 170
Novel Antitumor Cisplatin and Transplatin Derivatives Containing 1‑Methyl-7-Azaindole: Synthesis, Characterization, and Cellular Responses 164
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 139
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 137
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 135
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 122
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 120
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 119
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 117
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 117
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 116
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 116
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 116
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 114
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 114
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 114
Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of Guanine nucleotides in Platinum complexes with a single guanine ligand 114
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 114
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 113
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 113
A novel head-to-head conformer of d(GpG) cross-linked by Pt: New light on the conformation of such cross-links formed by Pt anticancer drugs 111
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 109
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 105
Chirality-Controlling Chelate (CCC) Ligands in Analogs of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG2 with CCC = N,N'-Dimethyl-2,3-diaminobutane 104
null 104
Bis[iodo(N,N,N′,N'',N''-pentamethyldiethyl-enetriamine- kappa N-3)platinum(II)] di-μ-iodobis[diiodoplatinate(II)] 102
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 102
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 102
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 102
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 102
Solution Behavior of Amidine Complexes: An Unexpected cis/trans Isomerization and Formation of Di- and Trinuclear Platinum(III) and Platinum(II) Species 100
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 100
Synthesis and X-ray crystal structure of a trans-dichloro(1-cyano-2,2-dimethylpropane)(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 94
Solvolysis of Platinum Complexes with Substituted Ethylenediamines in Dimethylsulfoxide 93
Factors Influencing the Configuration and Conformation of Diamine Chelate Rings in Platinum(II) Compounds: 2,4- Bis(methylamino)pentane Complexes 92
New steric hindrance approach employing the hybrid ligand 2-aminomethylpiperidine for diminishing dynamic motion problems of platinum anticancer drug adducts containing guanine derivatives 91
Effects of six-membered-ring conformation on the rotamer distribution and rate of atropisomerization in platinum(II)-guanine compounds: 2,4-bis(methylamino)pentane complexes 89
null 89
Structural characterization of the “lantern-shaped” platinum(III) complex [Pt2Cl2{N(H)C(But)O}4] 88
null 88
Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+ 87
Isolation, Characterization, and Kinetics of Formation of the cis and trans Isomers of Bis(acetonitrile)dichloroplatinum(II) 85
Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes 84
Synthesis and spectroscopic and structural characterization of different configurations of the tridentate amine ligand N,N’,N’’-trimethyldiethylenetriamine coordinated to platinum 82
trans-Chloridobis[(Z)-1-imino-1-methoxyethane-N](triphenylphosphane-P)platinum(II) chloride monohydrate 82
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 82
null 80
Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's 79
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 78
Cisplatin and zoledronic acid: two drugs combined in a Pt(II) complex with potential antitumor activity towards bone tumors and metastases 76
Platinum(II) complexes with the purine derivatives Penciclovir and Famciclovir; monoadducts with potential antitumor and antiviral activity 76
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 76
IRREVERSIBLE ADDITION OF CARBON NUCLEOPHILES TO ETHYLENE IN CATIONIC PLATINUM(II) COMPLEXES 76
Synthesis and X-Ray Structural Characterization of the First Unbridged Diplatinum(III) Compound: Bis[bis(1-imino-1-hydroxy-2,2-dimethyl-propane)-trichloroplatinum(III)] 75
Retro-Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate (CCC) Ligand Restriction of Guanine Dynamic Motion in (2,2'-Bipiperidine)PtG2 Complexes (G = Guanine Derivative) 74
Complessi antitumorali di platino a geometria trans 74
Sinthesis and stereochemical characterisation of platinum(II) complexes with the antiviral agents penciclovir and famciclovir 73
Synthesis and Crystal Structure of a Trans-Diaquabis(amidato) Complex of Platinum(II) 72
NUCLEOPHILIC-ATTACK OF METHANOL ON BIS(BENZONITRILE)DICHLOROPLATINUM - FORMATION OF MONO-IMIDO AND BIS-IMIDO ESTER DERIVATIVES 71
A trans-platinum complex showing higher antitumor activity than the cis congeners 71
Stereochemical Investigations of Cationic Olefin Complexes of Platinum(II) Containing Chiral Diamines: a Sequence of Four Asymmetric Centres (N, C, C and N) in the chelate ring 70
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 70
Cyclodextrin polymers as carriers for the platinum-based anticancer agent LA-12 70
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration 69
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 69
X-ray Structural Characterization of the Bis-Guanine Derivative of a Cisplatin Analogue Having Just One Proton on Each Coordinated Nitrogen and a Head-to-Head Conformation: [Pt{(±)-N,N'-dimethylbutane-2,3-diamine}(9-ethyl-guanine)2]dinitrate 68
Biochemical aspects of antitumor effects of a new platinum(IV) drug 68
Retro-modeling in Pt anticancer drug chemistry 67
null 67
Sinthesis and characterisation of the amidine complexes trans-[PtCl(NH3)(HN=C(NH2)R)2]Cl (R= Me,Ph,CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 66
null 66
Platinum Amides from Platinum Nitriles: X-ray Crystal Structures of the Unbridged Dinuclear Compounds Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)dichloro-platinum(II)] and Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)(1-amino-1-oxo-2,2-dimethylpropane)dichloro-platinum(II)] 65
X-ray Structure of the first Platinum Complexes with Z Configuration of the Iminoether Ligands: trans Dichlorobis(1-imino-1-methoxy- 2,2'-dimethylpropane)platinum(II) and trans-Tetrachlorobis(1-imino-1-methoxy-2,2'-dimethylpropane)platinum(IV) 62
A new generation of platinum anticancer complexes with trans geometry 61
Isomerism of amides coordinated to platinum - X-ray crystal structure of O-bonded acetamide in a platinum(II) complex 60
Isomerization of Platinum-Coordinated Iminoethers Induced by Spectator Ligands: Stabilization of the Z anti Configuration 60
null 58
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 58
Two polymorphs of potassium trichloro[diethyl (methylsulfinylmethyl)phosphonate-kS]platinum(II) with Z' = 1 and 3 in the space group P212121 55
null 55
Synthesis and Crystal Structure of the First Trinuclear Chloride-bridged Platinum(II) Complex with Mutually Perpendicular Co-ordination Planes: cyclo-Tri-mu-chloro-tris[chloro(1-hydroxy-1-imino-2,2-dimethylpropane)platinum(II)]-Dichloromethane (0.5/1) 55
MECHANISTIC AND STEREOCHEMICAL INVESTIGATION OF IMINO ETHERS FORMED BY ALCOHOLYSIS OF COORDINATED NITRILES - X-RAY CRYSTAL-STRUCTURES OF CIS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) AND TRANS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) 53
Nucleophilic Attack of Amine and Hydroxide to Platinum Dibenzonitrile Dichloride. Crystal structure of [Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl(NHCOPh)] (2) and cis-[Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl2(NCPh)](3) 53
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 53
null 52
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 50
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 48
SYNTHESIS, MUTAGENICITY, BINDING TO PBR-322 DNA AND ANTITUMOR-ACTIVITY OF PLATINUM(II) COMPLEXES WITH ETHAMBUTOL 48
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 48
Four- versus Five-coordination in Palladium(II) and Platinum(II) Complexes Containing 2,9-Dimethyl-1,10-phenanthroline (dmphen). Crystal Structures of [PtCl2(dmphen)] and [Pt(h2-C2H4)Cl2(dmphen)] 47
Synthesis and X-Ray Characterization of Two Unbridged Diplatinum(III) Compounds: cis and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 45
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 44
Stereochemically Controlled Ligands Influence Atropisomerization of Pt(II) Nucleotide Complexes. Evidence for Head-to-Head and Stable a Head-to-Tail Atropisomers 44
Viewing early stages of guanine nucleotide attach on Pt(II) complexes designed with in-plane bulk to trap initial adducts. Relevance to cis-Type Pt(II) anticancer drugs 43
New platinum antitumor complexes with chiral diamines 41
New concepts relevant to cisplatin anticancer activity from unique spectral features providing evidence that adjacent guanines in d(GpG), intrastrand-cross-linked at N7 by a cis-platinum(II) moiety, can adopt a head-to-tail arrangement 38
Kinetic study of the reaction between an antitumor 15N labeled trans- platinum iminoether complex and GMP by [1H,15N] HMQC NMR 38
Replacement of a NH3 by an iminoether in transplatin makes an antitumor drug from an inactive compound 34
Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle 34
Totale 8.352
Categoria #
all - tutte 36.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 44 52 54 95 153 123 42
2021/2022675 13 95 5 31 34 39 28 42 58 61 135 134
2022/20231.209 197 101 79 112 170 166 6 148 179 14 19 18
2023/2024399 31 63 10 33 38 144 2 14 7 4 1 52
2024/20251.296 48 31 125 32 20 78 115 87 59 66 182 453
2025/20261.263 364 140 139 282 279 59 0 0 0 0 0 0
Totale 8.527